CASI Pharmaceuticals Inc. (CASI) Is Down -41.36% in 2021 With Lots of Room to Run
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is -41.36% lower on its value in year-to-date trading and has touched a low of $1.46 and a high of
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is -41.36% lower on its value in year-to-date trading and has touched a low of $1.46 and a high of
100 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.28% of the
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is -38.64% lower on its value in year-to-date trading and has touched a low of $1.46 and a high of
99 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.22% of the
99 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.23% of the
94 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 34.98% while institutional investors hold 49.46% of the
How have the shares performed? CASI Pharmaceuticals Inc. (CASI) saw downtrend of -4.19% in the recent trading with $3.20 being its most recent. The current
CASI Pharmaceuticals Inc. (CASI) was up 4.24% up at ring of the bell last day. The company revised its business strategy it shared at the